Valproic acid radiosensitizes anaplastic thyroid cells through a decrease of the DNA damage repair capacity

PERONA, M.; IBAÑEZ, I.L.; THOMASZ, L.; VILLAVERDE, M.S.; OGLIO, R.; ROSEMBLIT, C.; GRISSI, C.; CAMPOS-HAEDO, M.; DAGROSA, M.A.; CREMASCHI, G.; DURÁN H; JUVENAL, G.J.

JOURNAL ENDOCRINOLOGY INVESTIGATION

Springer Science and Business Media Deutschland GmbH

Año: 2023

0391-4097

Background: Anaplastic thyroid cancer (ATC) represents a rare lethal human malignancy with poor prognosis. Multimodality treatment, including radiotherapy, is recommended to improve local control and survival. Valproic acid (VA) is a clinically available histone deacetylase inhibitor with a well-documented side effect profile. In this study, we aim to investigate the combined effect of VA with photon irradiation in vitro. Methods: Anaplastic thyroid cancer cells (8505c) were used to investigate the radiosensitizing effect of VA. Results: VA sensitized cells to photon irradiation. VA increased radiation-induced apoptosis and radiation-induced DNA damage measured by γH2AX foci induction. Furthermore, VA prolonged γH2AX foci disappearance over time in irradiated cells and decreased the radiation-induced levels of mRNA of key DNA damage repair proteins of the homologous recombination (HR) and the nonhomologous end joining (NHEJ) pathways. Conclusions: VA at a clinically safe dose enhance the radiosensitivity of 8505c cells through an increase in radiation-induced apoptosis and a disruption in the molecular mechanism of HR and NHEJ DNA damage repair pathways.